|
|
(PQA-5) DNA methylation and cancer prevention: duration and intensity of exercise
|
1R01CA179963-01
|
$559,672
|
$559,672
|
Bryan, Angela
|
UNIVERSITY OF COLORADO
|
|
|
(PQA1)Molecular mechanisms by which the diabetic drug metformin kills cancer cell
|
1R01CA180033-01
|
$295,065
|
$295,065
|
MISKIMINS, W
|
SANFORD RESEARCH/USD
|
|
|
(PQA2) MAMMALIAN REGENERATION, HIGH FAT DIETS, AND BREAST CANCER: A COMMON LINK?
|
1R01CA180070-01
|
$377,488
|
$377,488
|
HEBER-KATZ, ELLEN S.
|
WISTAR INSTITUTE
|
|
|
(PQA2) Reversing Carcinogenic Effect of Obesity on Basal-like Breast Cancer
|
1R21CA180134-01
|
$192,411
|
$192,411
|
HAYES, LIZA
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
|
(PQA4) GPS exposure to environments & relations with biomarkers of cancer risk
|
1R01CA179977-01
|
$733,604
|
$366,802
|
Kerr, Jacqueline
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
|
(PQA5) 'Dose and Mechanisms of Exercise in Breast Cancer Prevention'
|
1R01CA179992-01
|
$735,574
|
$735,574
|
JONES, LEE
|
DUKE UNIVERSITY
|
|
|
(PQC4) Fate of cells disseminating from human breast cancer xenografts
|
1R01CA180039-01
|
$325,775
|
$325,775
|
WERB, ZENA
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
|
(PQD3) Genetic Basis of Breast Cancer Resistance in BRCA1+ Carrier
|
1R21CA180008-01
|
$174,788
|
$174,788
|
WANG, SAN MING
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
|
(PQD4) SIGNS OF INFLAMMATORY BREAST CANCER ARE CAUSED BY STROMAL FIELD EFFECTS
|
1R01CA180061-01
|
$460,025
|
$460,025
|
Woodward, Wendy
|
UT MD ANDERSON CANCER CTR
|
|
|
2013 Annual Meeting of the American Society for Investigative Pathology
|
1R13CA177075-01
|
$15,000
|
$3,750
|
LUSCINSKAS, FRANCIS
|
AMERICAN SOCIETY/INVESTIGATIVE PATHOLOGY
|
|
|
2013, 2014 and 2015 Mammary Gland Biology Gordon Research Conference & Gordon Res
|
1R13CA177033-01
|
$5,000
|
$5,000
|
WOOD, TERESA
|
GORDON RESEARCH CONFERENCES
|
|
|
27-hydroxycholesterol as a link between obesity and breast cancer pathogenesis
|
1K99CA172357-01
|
$94,829
|
$94,829
|
NELSON, ERIK
|
DUKE UNIVERSITY
|
|
|
3-D Computer Modeling for Optimizing Body Image following Breast Reconstruction
|
5R01CA143190-04
|
$525,480
|
$525,480
|
Markey, Mia
|
UNIVERSITY OF TEXAS, AUSTIN
|
|
|
3D Digital Breast Phantoms For Multimodality Research
|
5R01CA134658-04
|
$299,362
|
$299,362
|
Segars, William
|
DUKE UNIVERSITY
|
|
|
3D Hybrid Optoacoustic-Ultrasonic System for Diagnostic Imaging of Breast Cancer
|
7R44CA128196-04
|
$241,275
|
$241,275
|
ORAEVSKY, ALEXANDER
|
TOMOWAVE LABORATORIES, INC.
|
|
|
3D Optical Imaging and Digital Xray of Breast Lesions
|
5R01CA097305-10
|
$327,581
|
$327,581
|
Boas, David
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
|
3D Photoacoustic Tomography (PAT)and Dynamic Contrast-Enhanced PAT Breast Imaging
|
5R01CA160850-02
|
$626,950
|
$626,950
|
KRUGER, ROBERT
|
OPTOSONICS, INC.
|
|
|
4D Microfluidic Platforms for Targeting Breast Cancer:Lymphatic Interactions
|
1R21CA175931-01
|
$198,360
|
$198,360
|
SLOANE, BONNIE
|
WAYNE STATE UNIVERSITY
|
|
|
53BP1-Mediated Regulation of DNA Repair and Chemoresistance
|
7R01CA169182-02
|
$309,504
|
$309,504
|
GANESAN, SHRIDAR
|
RBHS -CANCER INSTITUTE OF NEW JERSEY
|
|
|
7th International Conference on Clinical Cancer Prevention 2012 with Consensus Co
|
1R13CA171707-01
|
$20,000
|
$2,400
|
MEYSKENS, FRANK
|
UNIVERSITY OF CALIFORNIA-IRVINE
|
|
|
A Cancer Rainbow Mouse for the Simultaneous Assessment of Multiple Oncogenes
|
5R21CA173245-02
|
$240,536
|
$79,377
|
Caron, Marc
|
DUKE UNIVERSITY
|
|
|
A comprehensive approach to breast cancer susceptibility across the risk spectrum
|
5R01CA155767-03
|
$497,212
|
$497,212
|
Goldgar, David
|
UNIVERSITY OF UTAH
|
|
|
A Cyber-Informatics Approach to Studying Migration and Environmental Cancer Risk
|
5R01CA170508-02
|
$377,899
|
$188,950
|
Tourassi, Georgia
|
UT-BATTELLE, LLC-OAK RIDGE NATIONAL LAB
|
|
|
A Follow-up Study for Causes of Cancer in Black Women
|
5UM1CA164974-02
|
$2,686,982
|
$537,396
|
Rosenberg, Lynn
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
|
A Follow-up Study for Causes of Illness in Black Women
|
5R01CA058420-20
|
$1
|
$1
|
Rosenberg, Lynn
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
|
A Genetic Model for Early-Onset Breast and Colon Cancer in African Americans
|
7U01CA158428-02
|
$306,154
|
$153,077
|
Buckhaults, Phillip
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
|
A membrane-based immunotherapy for triple negative breast cancer
|
1R43CA176920-01
|
$144,759
|
$144,759
|
PACK, CHRISTOPHER
|
METACLIPSE THERAPEUTICS CORPORATION
|
|
|
A metabolic role for PML in tumor suppression
|
5R01CA142780-04
|
$329,206
|
$82,302
|
PANDOLFI, PIER PAOLO
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
|
A Narrowed Window for Targeting Metabolic Flexibility in Breast Cancer Prevention
|
1R01CA164166-01A1
|
$309,710
|
$309,710
|
MACLEAN, PAUL
|
UNIVERSITY OF COLORADO DENVER
|
|
|
A NOVEL BREAST CANCER BIOMARKER
|
5R01CA112021-09
|
$285,393
|
$285,393
|
SGROI, DENNIS
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
|
A Novel IgE Cancer Therapeutic Specific for the Epithelial Membrane Protein-2
|
1R21CA179680-01
|
$167,475
|
$55,267
|
Daniels-Wells, Tracy
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
|
A Novel Mechanism of PI3K Membrane Docking Promotes Lapatinib Resistance
|
5F31CA165819-02
|
$28,584
|
$28,584
|
Brady, Samuel
|
UT MD ANDERSON CANCER CTR
|
|
|
A NOVEL MICROFLUIDIC DEVICE FOR SELECTION AND OPTIMIZATION OF DRUG DELIVERY VEHIC
|
5R44CA139841-03
|
$619,304
|
$154,826
|
PRABHAKARPANDIAN, BALABHASKAR
|
CFD RESEARCH CORPORATION
|
|
|
A novel model system for risk assessment of BRCA carriers
|
5F31CA168180-02
|
$42,232
|
$42,232
|
Cochran, Rory
|
JOHNS HOPKINS UNIVERSITY
|
|
|
A Novel Plasminogen Receptor in Breast Cancer
|
5R01CA166473-02
|
$377,600
|
$377,600
|
MUELLER, BARBARA
|
TORREY PINES INST FOR MOLECULAR STUDIES
|
|
|
A Novel Theranostic Platform for Targeted Cancer Therapy and Treatment Monitoring
|
1R21CA174541-01
|
$199,013
|
$199,013
|
Bai, Mingfeng
|
UNIVERSITY OF PITTSBURGH
|
|
|
A Novel Therapy for the Treatment of Chest Wall Progression of Breast Cancer
|
2R44CA139644-02A1
|
$484,215
|
$484,215
|
Hill, Samuel
|
ROGERS SCIENCES, INC.
|
|
|
A Patient Centered Approach to Enrolling Rare Cancer Patients in Clinical Trials
|
5R44CA144362-03
|
$925,328
|
$231,332
|
Wiener, Matthew
|
PHARMATECH, INC.
|
|
|
A Phosphorylcholine Vesicle (PCV) Platform for Cancer Therapeutics
|
1R21CA167674-01A1
|
$176,008
|
$176,008
|
EMRICK, TODD
|
UNIVERSITY OF MASSACHUSETTS AMHERST
|
|
|
A RCT TO PROMOTE MAMMOGRAPHY ADHERENCE AMONG CHINESE IMMIGRANT WOMEN
|
5R01CA142941-04
|
$532,243
|
$532,243
|
WANG, JUDY
|
GEORGETOWN UNIVERSITY
|
|
|
A Real-Time Feedback System For Radiological Reporting To Reduce Diagnostic Varia
|
1F31CA171789-01A1
|
$42,232
|
$42,232
|
Gimenez, Francisco
|
STANFORD UNIVERSITY
|
|
|
A Role for the Novel Poly(A) RNA-Binding Protein, ZC3H14, in Breast Cancer
|
5F31CA168321-02
|
$30,912
|
$30,912
|
Wigington, Callie
|
EMORY UNIVERSITY
|
|
|
A stem cell strategy to induce tumor stasis and inhibit metastasis of breast canc
|
1R01CA172480-01A1
|
$382,384
|
$382,384
|
Wang, Jianjun
|
WAYNE STATE UNIVERSITY
|
|
|
A Strategy for Reactivating p53 in Cancer Stem Cells Using a Novel HdmX Inhibitor
|
1R21CA178327-01
|
$206,843
|
$206,843
|
Jackson, Mark
|
CASE WESTERN RESERVE UNIVERSITY
|
|
|
A Surface Activable Nanoemulsion platform for Breast Cancer Diagnosis and Therapy
|
5R01CA155432-03
|
$330,610
|
$330,610
|
Mulder, Willem
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
|
|
A Systems Genetics Analysis of Cancer Risk, Progression and Therapeutic Response
|
5U01CA084244-15
|
$699,208
|
$139,842
|
BALMAIN, ALLAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
|
A university-industry partnership for improving the imaging performance of digita
|
5R01CA148053-04
|
$272,953
|
$272,953
|
ZHAO, WEI
|
STATE UNIVERSITY NEW YORK STONY BROOK
|
|
|
A VASCULARIZED MODELOF HUMAN BRAIN METASTASIS FOR SCREENING OF ANTI-CANCER DRUGS
|
N43CO130027-000
|
$299,986
|
$299,986
|
NEUMANN, THOMAS
|
NORTIS, INC.
|
|
|
AANCART: The National Center for Reducing Asian American Cancer Health Disparitie
|
3U54CA153499-04S1
|
$112,000
|
$28,000
|
CHEN, MOON
|
UNIVERSITY OF CALIFORNIA DAVIS
|
|
|
AANCART: The National Center for Reducing Asian American Cancer Health Disparitie
|
3U54CA153499-04S2
|
$64,777
|
$16,194
|
CHEN, MOON
|
UNIVERSITY OF CALIFORNIA DAVIS
|
|
Total relevant funding to Breast for this search: $559,172,103
|
